ABBOTT LABORATORIES — Director's Dealing 2016

Mar 2, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2016-02-29

Reporting Person: Pavee Jean-Yves (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-29	Common shares without par value	A	11394	—	Acquired	40094	Direct
2016-02-29	Common shares without par value	F	2280	$39.52	Disposed	37814	Direct
2016-02-29	Common shares without par value	S	1665	$39.235	Disposed	36149	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	2935	Indirect
Common shares without par value	2967	Indirect
Common shares without par value	2966	Indirect
Common shares without par value	2966	Indirect

Footnotes

F1: Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of February 29, 2016.

F3: The reporting person disclaims beneficial ownership of all securities held by his daughter.

F4: The reporting person disclaims beneficial ownership of all securities held by his son.